Please join us for a special series of online seminars for people affected by hereditary breast and ovarian cancer.
Please join us for our next online seminar for people affected by hereditary breast and ovarian cancer.
November 14, 2016
Dr. Shannon Puhalla, Director, Breast Cancer Clinical Research Program, University of Pittsburgh Cancer Institute discusses the BROCADE 3 Study. Brocade3 is a research study evaluating the safety and effectiveness of an investigational medication in addition to treatment with chemotherapy for patients with metastatic or locally advanced BRCA associated, HER2-negative breast cancer.